Question 1

What is cholestasis, progressive familial intrahepatic, 12?

Accepted Answer

Cholestasis, progressive familial intrahepatic, 12 is a disorder primarily affecting liver function with disturbances in bile flow. The condition is genetically linked to pathogenic variants in the VPS33B gene and is inherited in an autosomal recessive pattern. Affected individuals, often presenting in early childhood, exhibit persistent liver-related abnormalities, and the exact frequency of this condition in the general population remains unknown. With ongoing research and evolving supportive care, the outlook is being continuously redefined for those with this diagnosis.

Question 2

What are the symptoms of cholestasis, progressive familial intrahepatic, 12?

Accepted Answer

The clinical presentation of this condition is marked by a group of characteristic findings. Nearly all affected individuals exhibit persistent hyperbilirubinemia, pruritus, proteinuria, conjugated hyperbilirubinemia, and cholestasis, which are considered hallmark features. In addition, some individuals may experience splenomegaly, jaundice, elevated levels of liver enzymes such as aspartate and alanine aminotransferase, prolonged partial thromboplastin time, short stature, hepatomegaly, and increased serum bile acid concentrations. Not all individuals experience every symptom, and severity varies widely between affected individuals.

Question 3

What causes cholestasis, progressive familial intrahepatic, 12?

Accepted Answer

This condition is caused by pathogenic variants in the VPS33B gene, which plays a critical role in intracellular protein trafficking. Disruption of this gene affects normal liver function, contributing to the accumulation of bile and resultant cholestasis. The condition is inherited in an autosomal recessive manner, meaning that an affected individual inherits two altered copies of the VPS33B gene, one from each parent. Parents who carry one copy of the variant are typically unaffected, but each child of two carrier parents has a 25% chance of being affected, making genetic counseling an important step for families. Associated genes include VPS33B.

Question 4

How is cholestasis, progressive familial intrahepatic, 12 inherited?

Accepted Answer

cholestasis, progressive familial intrahepatic, 12 follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How is cholestasis, progressive familial intrahepatic, 12 diagnosed?

Accepted Answer

Diagnosis of cholestasis, progressive familial intrahepatic, 12 is confirmed through molecular genetic testing that identifies pathogenic variants in the VPS33B gene. In addition, clinical evaluation that focuses on characteristic findings such as persistent cholestasis, pruritus, and abnormal liver enzyme levels supports the diagnosis. Since the symptoms of this condition can overlap with other disorders, definitive diagnosis relies on genetic testing rather than clinical features alone.

Question 6

Are there treatments for cholestasis, progressive familial intrahepatic, 12?

Accepted Answer

Currently, management of this condition focuses on supportive care and symptom control, as there are no treatments specifically approved for cholestasis, progressive familial intrahepatic, 12. Treatment is tailored to the individual and typically involves a multidisciplinary team that addresses liver function, pruritus, and other complications as they arise. Regular surveillance is an essential part of long-term care, helping to monitor and identify emerging complications early. In addition, genetic counseling is recommended to help families understand the inheritance pattern and to guide future family planning.

Question 7

Are there clinical trials for cholestasis, progressive familial intrahepatic, 12?

Accepted Answer

Yes, there is currently 1 active clinical trial for cholestasis, progressive familial intrahepatic, 12 registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 8

What complications can arise from cholestasis, progressive familial intrahepatic, 12?

Accepted Answer

Cholestasis, progressive familial intrahepatic, 12 can lead to several complications related to liver function. Some individuals may experience worsening liver dysfunction, which can cause symptoms like jaundice and abdominal swelling. Additionally, there can be issues with growth, such as short stature, and other complications like splenomegaly. Regular monitoring is important to catch these issues early.

Question 9

How does cholestasis, progressive familial intrahepatic, 12 affect daily life for patients?

Accepted Answer

Living with cholestasis, progressive familial intrahepatic, 12 can impact daily life in various ways. Patients often deal with symptoms like itching and fatigue, which can make everyday activities challenging. Regular medical appointments and monitoring are also necessary, which can require time and planning. Support from family and healthcare providers is essential to help manage these challenges.

Question 10

What is the long-term prognosis for someone with cholestasis, progressive familial intrahepatic, 12?

Accepted Answer

The long-term prognosis for individuals with cholestasis, progressive familial intrahepatic, 12 varies widely. Some may experience stable liver function, while others might have episodes of worsening liver issues. With modern care and support, many individuals are able to manage their condition into later childhood and beyond. Ongoing research and improvements in treatment are helping to enhance outcomes.

Question 11

What should families consider when planning for the future with cholestasis, progressive familial intrahepatic, 12?

Accepted Answer

Families with cholestasis, progressive familial intrahepatic, 12 should consider genetic counseling when planning for the future. Since the condition is inherited, understanding the risks for future children is important. Additionally, families should think about the ongoing medical care and support their affected child will need. Connecting with specialists who understand this condition can also provide valuable guidance.

Kisho

cholestasis, progressive familial intrahepatic, 12

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Recent Publications

cholestasis, progressive familial intrahepatic, 12

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is cholestasis, progressive familial intrahepatic, 12?

What are the symptoms of cholestasis, progressive familial intrahepatic, 12?

What causes cholestasis, progressive familial intrahepatic, 12?

How is cholestasis, progressive familial intrahepatic, 12 inherited?

How is cholestasis, progressive familial intrahepatic, 12 diagnosed?

Are there treatments for cholestasis, progressive familial intrahepatic, 12?

Are there clinical trials for cholestasis, progressive familial intrahepatic, 12?

What complications can arise from cholestasis, progressive familial intrahepatic, 12?

How does cholestasis, progressive familial intrahepatic, 12 affect daily life for patients?

What is the long-term prognosis for someone with cholestasis, progressive familial intrahepatic, 12?

What should families consider when planning for the future with cholestasis, progressive familial intrahepatic, 12?

Explore clinical features

Recent Publications